Pathological Type，Gene Mutation and Clinical Characteristics of Unilateral Primary Aldosteronism

Qifu Li

Status: Enrolling

Conditions: Primary Aldosteronism

Treatments: Other: Tissue specimens were stained by histopathology of hematoxylin-eosin

Study type: Observational

Funder types: Other

Identifiers

NCT06597630

PGC-UPA-2024

Details and patient eligibility

About

1. Aim to investigate the pathological feature of UPA in Asians
2. To clarify the relationship between pathology, clinical phenotype, genetic mutation and surgical outcome of UPA in Asians.
3. To explore a new pathological type of unilateral primary aldosterone

Full description

The multi-center expert team led by Tracy Ann Williams formulated the International Consensus on the Pathological Diagnosis of Unilateral aldehyde disease, which standardized the pathological classification of unilateral PA. The previous retrospective study of the research group found that the pathologic types of unilateral primary aldosteronoma were mainly classical, and aldosteronoma was the most common. There was no significant difference in clinical features and postoperative biochemical remission rate between patients with classic and non-classic, but the clinical prognosis of the latter group was worse than that of the classical group. However, the study was retrospective and there may be inclusion bias. The pathologic distribution and clinical features of unilateral aldehyde disease are not completely clear and need to be discussed in prospective studies.Therefore，this study aims to determine the composition ratio of different pathological types in patients with unilateral procaldosis enrolled in our center. Gene mutation of different pathological types, the relationship between pathology and clinical phenotype, gene mutation, etc.

Enrollment: 100 estimated patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. No gender limitation;
2. Age 18-80 years old;
3. The patient was diagnosed with UPA and underwent total adrenal resection.

Exclusion criteria

1. Bilateral disease
2. Partial of no biochemical response in follow-up
3. partial adrenalectomy

Trial design

100 participants in 1 patient group

unilateral primary aldosteronism group

Description:

The patient was diagnosed with unilateral primary aldosteronism and underwent total adrenal resection

Treatment:

Other: Tissue specimens were stained by histopathology of hematoxylin-eosin